Stock Earnings

Question 1

Shenzhen Hepalink Pharmaceutical Group Co Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Shenzhen Hepalink Pharmaceutical Group Co Ltdの総資産は$17,343で、純profitは$646です。

Question 2

SHEZFの主要な財務比率は何ですか？

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltdの流動比率は3.33、純利益率は12.23、1株当たり売上高は$3.59です。

Question 3

Shenzhen Hepalink Pharmaceutical Group Co Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltd largest revenue segment is Preparation, at a revenue of 2,986,074,622 in the most earnings release.For geography, Europe is the primary market for Shenzhen Hepalink Pharmaceutical Group Co Ltd, at a revenue of 2,372,845,163.

Question 4

Shenzhen Hepalink Pharmaceutical Group Co Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Shenzhen Hepalink Pharmaceutical Group Co Ltdの純profitは$646です。

Question 5

Shenzhen Hepalink Pharmaceutical Group Co Ltdに負債はありますか？

Accepted Answer

yes、Shenzhen Hepalink Pharmaceutical Group Co Ltdの負債は5,194です。

Question 6

Shenzhen Hepalink Pharmaceutical Group Co Ltdの発行済株式数は何株ですか？

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltdの総発行済株式数は1,467.29株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5,260	5,280	5,445	7,159	6,365	5,332
Revenue Growth (YoY)	-6%	-3%	-24%	12%	19%	15%
Cost of Revenue	3,655	3,532	4,501	4,863	4,367	3,300
Gross Profit	1,605	1,748	944	2,295	1,998	2,031
Selling, General & Admin	855	781	930	972	878	767
Research & Development	233	203	173	244	216	154
Operating Expenses	1,297	1,099	1,232	1,292	1,186	996
Other Non Operating Income (Expenses)	0	-14	-66	1	-4	-1
Pretax Income	442	726	-928	829	222	1,327
Income Tax Expense	58	101	-126	114	-11	306
Net Income	404	646	-783	727	240	1,024
Net Income Growth	-267%	-183%	-208%	202.99%	-77%	-3%
Shares Outstanding (Diluted)	1,467.29	1,467.29	1,467.29	1,467.29	1,467.29	1,467.3
Shares Change (YoY)	0%	0%	0%	0%	0%	18%
EPS (Diluted)	0.27	0.44	-0.53	0.49	0.16	0.7
EPS Growth	-267%	-183%	-208%	202%	-77%	-18%
Free Cash Flow	1,751	1,991	-46	-979	-200	-175
Free Cash Flow Per Share	1.19	1.35	-0.03	-0.66	-0.13	-0.11
Gross Margin	30.51%	33.1%	17.33%	32.05%	31.39%	38.09%
Operating Margin	5.85%	12.27%	-5.28%	14.01%	12.74%	19.41%
Profit Margin	7.68%	12.23%	-14.38%	10.15%	3.77%	19.2%
Free Cash Flow Margin	33.28%	37.7%	-0.84%	-13.67%	-3.14%	-3.28%
EBITDA	--	744	-188	1,095	911	1,136
EBITDA Margin	--	14.09%	-3.45%	15.29%	14.31%	21.3%
D&A For EBITDA	--	96	100	92	100	101
EBIT	308	648	-288	1,003	811	1,035
EBIT Margin	5.85%	12.27%	-5.28%	14.01%	12.74%	19.41%
Effective Tax Rate	13.12%	13.91%	13.57%	13.75%	-4.95%	23.05%

Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF) Price

SHEZF Stock Price Chart

SHEZF Income

Follow-Up Questions